Angels for Change has named Vimala Raghavendran, Vice President at the U.S. Pharmacopeia (USP), as the 2025 Change Maker of the Year. Raghavendran created the groundbreaking Medicine Supply Map, a first-of-its-kind tool used nationwide to uncover vulnerabilities in the medicine supply chain and prevent drug shortages.
Her innovation has powered lifesaving work at A4C and beyond — strengthening access to critical medicines and protecting patients.
The newest Change Maker Chronicle is here! This issue shares powerful stories, advocacy updates, and partner impact. Inside you will find ongoing efforts to end drug shortages and improve patient access. Discover key milestones and see how support drives meaningful change.
Healthcare Brew explores how Angels for Change is addressing the national drug shortage crisis. From our Drug Shortage Hotline—which has helped patients access more than 750,000 medicines since 2022—to efforts that strengthen supply chains and raise awareness, the article highlights the urgent need for solutions and the impact of collaboration across patients, providers, and industry.
Healthcare Brew explores how Angels for Change is addressing the national drug shortage crisis. From our Drug Shortage Hotline—which has helped patients access more than 750,000 medicines since 2022—to efforts that strengthen supply chains and raise awareness, the article highlights the urgent need for solutions and the impact of collaboration across patients, providers, and industry.
On August 27, 2025, Angels for Change was featured at the Reagan-Udall Foundation for the FDA’s Public Meeting on Demand Forecasting for Controlled Substances in Washington, DC. Our founder, Laura Bray, was a featured panelist.
In our public comments for the record, we highlighted how outdated and inflexible forecasting processes are leaving patients without access to critical medicines. We called for a more transparent, patient-centered approach that:
Anchors demand forecasting in real-world patient care rather than sales data
Brings together stakeholders across the supply chain, prescribers, and patient advocates
Builds regulatory flexibility to respond to changing patient needs
“We must anchor forecasting in patient care, reimbursement realities, and supply chain insight — not in sales numbers skewed by a constrained, quota-driven market.”
The panel discussion, moderated by Susan Winkler CEO of the Reagan-Udall foundation, brought together leaders from across healthcare to examine the challenges of forecasting controlled substances, the importance of accurate data, and the broader impact on patient access.
Read our full public comments submitted during the meeting below.
Angels for Change was featured in the Children’s Hospital Association article, Ensuring Access to Critical Medicines for Children. The piece highlights the ongoing work to address pediatric drug shortages, including how initiatives like Project PROTECT collaborate with manufacturers to prevent disruptions and secure access to critical medicines.
The article shares how shortages of essential treatments—such as electrolytes for NICU babies—can impact care, and why building a more resilient supply chain is essential for children and families nationwide.
Angels for Change Releases 2024 Annual Report
Tampa, FL — Angels for Change has released its 2024 Annual Report, offering a comprehensive look at the organization’s impact over the past year in addressing drug shortages and advancing patient access across the pharmaceutical supply chain.
In a year that saw the highest number of drug shortages ever recorded—323 active shortages reported nationwide—Angels for Change remained committed to collaborative, systems-based solutions. The report outlines measurable progress across advocacy, policy engagement, emergency response, and supply chain resilience.
Key highlights include:
Over 750,000 treatments accessed through our Drug Shortage Hotline and Global Supply Sharing Network
A 98% success rate in addressing patient needs during active shortages
9 essential medicines protected through Project PROTECT
Ongoing leadership on two federal task forces focused on drug shortages
National growth through media coverage, strategic partnerships, and grassroots engagement
As the only nonprofit patient advocacy organization solely focused on ending drug shortages, Angels for Change continues to drive change through cross-sector collaboration, policy leadership, and patient-centered action.
Read the full report to learn more about our 2024 impact and the work ahead.
Angels for Change Statement Included in Congressional Hearing on Strengthening the U.S. Health Care Supply Chain
Last month, the House Energy & Commerce Health Subcommittee held a critical hearing titled: “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.”
Angels for Change submitted a formal statement for the record—bringing the voice of the patient directly to policymakers.
New Legislation Takes Aim at Drug Shortages—Angels for Change Recognized in MAPS Act Launch
Angels for Change is officially recognized in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, a groundbreaking bill introduced by Representatives Doris Matsui (D-CA) and Dan Crenshaw (R-TX). This legislation directly addresses vulnerabilities in the drug supply chain by requiring greater transparency, mapping critical drug components, and identifying potential risks before they impact patient care
The latest edition of The Change Maker Chronicle is here!
We're taking bold steps and sharing real stories as we push the movement to end drug shortages to the NEXT LEVEL.
In this issue, hear directly from Shortage Warriors whose voices are driving change, explore major advocacy milestones, and get a first look at what’s ahead in Q3. From national policy impact to community-powered action, this edition shows what’s possible when Change Makers like you stand with us.
👉 Read the Changemaker Chronicle: Issue 12, Quarter 2, 2025
Together, we’re leveling up the mission—because every patient deserves access to the medicine they need.
At the Oley Foundation, our mission for over four decades has been to support people who rely on parenteral and enteral nutrition (PN and EN). As CEO, I’ve witnessed firsthand how fragile our drug supply chain can be—especially for the medically complex patients who depend on life-sustaining therapies every single day.
Until recently, it felt like we were fighting that battle alone.
That changed two years ago, when I first connected with Laura Bray, founder of Angels for Change. Laura had been working closely with manufacturers, distributors, and government agencies to improve access to sterile, generic injectable medications. While her focus spanned many therapies, one kept surfacing in her data: parenteral nutrition.
A single PN bag can contain 40–70 ingredients, each one sterile, and many sourced as generic injectables—often among the most at-risk for shortage. In hospitals, PN is compounded daily. At home, it’s delivered weekly. Any break in the chain can be catastrophic.
A Shared Purpose
From our first conversation, it was clear: Angels for Change and the Oley Foundation weren’t just aligned in mission—we shared values.
Laura’s patient-centered approach, her respect for lived experience, and her deep dive into shortage data resonated with everything we advocate for at Oley. Together, we committed to changing the narrative from quiet resignation—“you get what you get, so don’t pitch a fit”—to one of action, advocacy, and accountability.
Real-World Collaboration
Over the past two years, our partnership has taken many forms:
Emergency Response: In September 2024, when a hurricane disrupted a major manufacturer’s operations, Angels for Change activated its national network, while Oley mobilized our support lines. Together, we ensured that vulnerable home infusion patients didn’t fall through the cracks.
National Convenings: Laura invited me to speak at several supply chain resilience panels—always making sure the patient voice was part of the conversation. In turn, Oley amplified Angels for Change’s proposals at our forums, giving them the weight of real community experience.
Joint Advocacy: In March 2025, I was proud to join Laura in briefing the Republican Doctor Caucus on Capitol Hill. We spotlighted how drug shortages endanger not just PN patients—but our entire healthcare system.
It’s Personal, Too
This partnership isn’t just strategic—it’s personal. Laura and I check in often, not just to share data or plan advocacy, but to support one another. We celebrate the wins—like securing an emergency line item in a state budget—and we troubleshoot the tough moments, when shortages reappear or policy progress stalls.
In a field where organizations often operate in silos, our collaboration stands out. Two women, leading two nonprofits, with one shared purpose: making sure no patient goes without the therapy they need.
Looking Ahead
Our joint goal remains simple and urgent: A day when every patient—no matter where they live—receives their full, customized therapy exactly when it’s needed.
I’m honored to stand beside Laura Bray and the Angels for Change team in this fight—and deeply grateful for the friendship, trust, and shared determination that powers our work.
— Beth Gore, PhD
Chief Executive Officer
The Oley Foundation
